FDA Adverse Event Injury Summary report: N

XENMATRIX AB

MDR report key: 6166223 · Received December 12, 2016

Report

Report Number
1213643-2016-00567
Event Type
Injury
Date Received
December 12, 2016
Date of Event
October 17, 2016
Report Date
December 12, 2016
Manufacturer
DAVOL INC., SUB. C.R. BARD, INC.
Product Code
PIJ
PMA / PMN Number
K151177
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BASED ON THE INFORMATION PROVIDED AND THE PATIENT'S COMPLEX MEDICAL/SURGICAL HISTORY, NO CONCLUSION CAN BE MADE AT THIS TIME. INFECTION IS A KNOWN INHERENT RISK OF ANY SURGICAL PROCEDURE, THE WARNING SECTION OF THE IFU STATES, "THIS DEVICE IS NOT INDICATED FOR THE TREATMENT OF INFECTION. IF AN INFECTION DEVELOPS, TREAT THE INFECTION AGGRESSIVELY." A REVIEW OF THE MANUFACTURING RECORDS WAS PERFORMED AND FOUND THAT THE LOT WAS MANUFACTURED TO SPECIFICATION. IF ADDITIONAL INFORMATION IS PROVIDED, A SUPPLEMENTAL MDR WILL BE SUBMITTED. THE INFORMATION PROVIDED BY BARD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BARD. DEVICE REMAINS IMPLANTED.

Description of Event or Problem · 1

IT WAS REPORTED TO DAVOL THAT A PATIENT WHO IS PART OF A CLINICAL STUDY EXPERIENCED A POST SURGICAL SITE INFECTION. AS REPORTED THE PATIENT UNDERWENT IMPLANT OF THE XENMATRIX AB GRAFT ON (B)(6) 2016. DURING A FOLLOW UP VISIT, THE PATIENT WAS NOTED TO HAVE A PURULENT AND SEROSANGUINOUS COLLECTION. A SURGICAL DRAIN WAS PLACED ON (B)(6) 2016 IN THE LEFT UPPER QUADRANT IN THE INTRAPERITONEAL SPACE. THIS DRAIN WAS SUBSEQUENTLY REMOVED ON (B)(6) 2016. A SECOND DRAIN WAS PLACED ON (B)(6) 2016 IN THE RIGHT UPPER QUADRANT, RETRO-RECTUS SPACE. THIS DRAIN WAS REMOVED ON (B)(6) 2016. PATIENT WAS DIAGNOSED WITH A SURGICAL SITE INFECTION WITH PURULENT DRAINAGE FROM THE DEEP INCISION. CULTURES WERE OBTAINED WITH BACTERIA IDENTIFIED AS ESCHERICHIA COLI, KLEBSIELLA, ENTEROCOCCUS AND CANDIDA. THIS ADVERSE EVENT WAS CONSIDERED SEVERE AND REQUIRED PROLONGED HOSPITALIZATION AND ADDITIONAL MEDICAL/SURGICAL TREATMENT. THE PATIENT IS NOTED TO HAVE RECOVERED WITH THE INFECTION RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
817870 XENMATRIX AB PORCINE SURGICAL MESH PIJ DAVOL INC., SUB. C.R. BARD, INC. NA HUAS0662

Patients

Seq Age Sex Outcome Treatment
1 41 YR Hospitalization| R